Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding.
about
EBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases.EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomesKaposi's Sarcoma Herpesvirus Genome PersistenceSimilarities between the Epstein-Barr Virus (EBV) Nuclear Protein EBNA1 and the Pioneer Transcription Factor FoxA: Is EBNA1 a "Bookmarking" Oncoprotein that Alters the Host Cell Epigenotype?In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin.EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin.Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.Nuclear import of Epstein-Barr virus nuclear antigen 1 mediated by NPI-1 (Importin alpha5) is up- and down-regulated by phosphorylation of the nuclear localization signal for which Lys379 and Arg380 are essential.Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses.Live-cell imaging reveals multiple interactions between Epstein-Barr virus nuclear antigen 1 and cellular chromatin during interphase and mitosisThe analysis of EBV proteins which are antigenic in vivo.Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1).Stability without a centromere.Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome.Expression of a nuclear and a cytoplasmic Epstein-Barr virus early antigen after DNA transfer: cooperation of two distant parts of the genome for expression of the cytoplasmic antigenSegregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation.Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1.Isolation of human sequences that replicate autonomously in human cellsA second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein.Deletion mutants that affect expression of Epstein-Barr virus nuclear antigen in COS-1 cells after gene transfer with simian virus 40 vectors containing portions of the BamHI K fragmentIdentification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis.Latent and viral replicative transcription in vivo from the BamHI K fragment of Epstein-Barr virus DNA.Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and HConstitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication.Expression in COS-1 cells of Epstein-Barr virus nuclear antigen from a complete gene and a deleted geneCharacterization of a cDNA clone corresponding to a transcript from the Epstein-Barr virus BamHI M fragment: evidence for overlapping mRNAs.Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats.A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus.Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons.Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genomeThe Epstein-Barr Virus EBNA1 Protein.The epigenetic regulation of autonomous replicons.Coupling of mitotic chromosome tethering and replication competence in epstein-barr virus-based plasmids.Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virusMapping EBNA-1 domains involved in binding to metaphase chromosomes.Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which Is mediated by the viral E2 protein and its binding sites.
P2860
Q24529069-81B75620-C9C2-4A32-B217-422909B4F623Q24675498-C4D24DDD-B291-4148-8431-5F122D94D8C2Q26738483-F3E7E19C-92C0-4A10-92B8-E55E166EF0F9Q26823342-B9BE9A8B-2C5D-41F1-BA13-766A465D16D5Q31122638-077DC0BD-C819-425F-8137-6DA5A2CA7991Q33782382-4D7FDEC1-BECB-4897-AF6C-65FE26203B8EQ33860748-E502AE73-5143-4547-A275-7EA44FCA8738Q33880983-02D74407-0BB2-4E23-876E-E6E69E7BB0A3Q33884073-86FAB060-D4B1-4A84-8868-ACB97A9B143CQ34332147-35900EBD-BDFA-437E-AC9F-5B6C6E6C8BB8Q34353280-627E26E9-61E7-4393-9C8C-B504038C3E49Q35101324-2E720875-8DA1-4D08-96F2-5473A4224EADQ35943704-3E341475-8436-4DE7-9804-339FCC56AAF3Q35999054-A9A9D1A6-8F8D-44AB-9B10-A2D97C0693B1Q36000904-366E049C-2777-414D-9B4C-F7F3161218DCQ36185004-B5D718AC-AB3F-4A2E-BAB3-AE8EDFCF6307Q36244523-5E2540B7-76D9-4154-BA9D-44301AD460E6Q36273710-C7D886B0-2000-4557-9B67-25FE654371C3Q36471992-97196218-7F32-44A5-B402-3BDB080265EEQ36634587-1802CE0B-5B01-4A26-A836-08E4386D1A73Q36767535-5337B09E-EFD5-438D-B6E3-79A51198EB82Q36854742-1BA5BC2C-8841-4DE6-A38A-9BF2B5326509Q36862042-BB4F201C-3F4F-455C-8F4E-B80B53F805F6Q36894532-4519AC13-F48F-467D-A943-C14613B2D2E1Q36901311-0D077558-BABC-4E4A-A37A-A4C758CD572BQ36903105-677D8596-3B45-4662-8E71-68D54CCBC745Q36904325-7F347140-F711-40A9-8A8C-CF36A7E32552Q36917559-D027BB6E-8545-478C-8513-4B060476B2BFQ36918897-E6CA45E7-D9B8-4403-A6C1-244589FC6DB3Q37125296-83C89F7E-D32B-4DC2-BC4A-A48F53589B3AQ37531595-0AB9B2C1-14AD-40DA-B9D8-0AC37B1DA99BQ37538524-22D2443A-2905-4C7E-944A-C9C7B9F58C8AQ37543048-139F38B4-18E9-438C-89D7-545070BDD720Q37688813-35DB2DCA-D281-48FA-956B-0D6D1FCCE0BBQ38166365-3FE5FFB6-3A8F-4BED-B9F5-1749EAD83222Q38472362-EDB2816A-582F-44CB-BC68-CFC9FA224CBAQ39530529-DDDAE1D7-35DD-46E1-972F-376D2A58A163Q39549892-7FFF18CC-1AA1-4E86-AD31-68270907480DQ39550682-198B0B48-FD81-4EDD-8106-041E125B1B3EQ39550694-81925B3C-44CD-466E-A247-8BAA5631265A
P2860
Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1983
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Two Epstein-Barr viral nuclear ...... ology, and chromosome binding.
@en
Two Epstein-Barr viral nuclear ...... ology, and chromosome binding.
@nl
type
label
Two Epstein-Barr viral nuclear ...... ology, and chromosome binding.
@en
Two Epstein-Barr viral nuclear ...... ology, and chromosome binding.
@nl
prefLabel
Two Epstein-Barr viral nuclear ...... ology, and chromosome binding.
@en
Two Epstein-Barr viral nuclear ...... ology, and chromosome binding.
@nl
P2093
P2860
P356
P1476
Two Epstein-Barr viral nuclear ...... ology, and chromosome binding.
@en
P2093
P2860
P304
P356
10.1073/PNAS.80.24.7650
P407
P577
1983-12-01T00:00:00Z